Cite
HARVARD Citation
Idris, I. et al. (2015). A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK. Journal of medical economics. pp. 273-282. [Online].